MiR-130a-3p suppresses colorectal cancer growth by targeting Wnt Family Member 1 (WNT1)
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Bioengineered
- Vol. 12 (1) , 8407-8418
Abstract
The microRNA miR-130a-3p (miR-130a-3p) has anti-tumor activity against numerous cancer types. Further, miR-130a-3p may target Wnt signaling, which is a critical pathway regulating tumorigenesis. Functions of miR-130a-3p in colorectal cancer (CRC) and contributions of Wnt1 pathway modulation, however, have not been examined, hence the exploration on these two aspects. In this study, in comparison with normal controls, both CRC tissue and multiple CRC cell lines showed downregulated miR-130a-3p. MiR-130a-3p overexpression contributed to a decrease in CRC cell proliferation. Additionally, its overexpression also caused reduced expression of WNT Family Member 1 (WNT1) and downstream WNT pathway factors c-myc and cyclin D1. Dual-luciferase assay revealed WNT1 as a direct target of miR-130a-3p, and further the inhibitory effect of miR-130a-3p on c-myc and cyclin D1 was proved to be reversed by overexpressed WNT1. Collectively, miR-130a-3p inhibits CRC growth by directly targeting WNT1, and miR-130a-3p and WNT1 pathway-associated factors are defined as potential targets for CRC treatment.Keywords
Funding Information
- Technological Innovation Major Project of Guangan City (2019SYF10)
This publication has 33 references indexed in Scilit:
- miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3Cancer Letters, 2012
- MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CMLJournal of Cell Communication and Signaling, 2011
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21Cancer Cell, 2010
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor OutcomeThe American Journal of Pathology, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- The many ways of Wnt in cancerCurrent Opinion in Genetics & Development, 2007
- Wnt/β-Catenin Signaling in Development and DiseaseCell, 2006
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI: Journal of the National Cancer Institute, 2004
- Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative SurvivalCancer Research, 2004